Model Number CDS0601-XTR |
Device Problem
Adverse Event Without Identified Device or Use Problem (2993)
|
Patient Problems
Angina (1710); Dyspnea (1816); High Blood Pressure/ Hypertension (1908); Mitral Valve Stenosis (1965); Pleural Effusion (2010); Pulmonary Edema (2020); Heart Failure/Congestive Heart Failure (4446); Tricuspid Valve Insufficiency/ Regurgitation (4453)
|
Event Date 05/08/2023 |
Event Type
Injury
|
Event Description
|
This report is being filed due to worsening heart failure requiring treatment and mitral stenosis.Crd_956 - mitraclip china pms.Patient id: (b)(6).It was reported that on (b)(6) 2022, the patient presented with degenerative mitral regurgitation (mr) with mitral annular calcification, posterior leaflet prolapse and flail.Two mitraclips were implanted, reducing the mr to grade 1+.There was no device deficiency.On (b)(6)2023, the patient was admitted to the hospital with repeated chest tightness, dyspnea, and worsening heart failure was diagnosed.Per imaging, pleural effusions were noted on both sides with scattered inflammation and exudation in both lungs.Left atrial enlargement and aorta calcification, mild tricuspid regurgitation, moderate pulmonary hypertension, a trace left to right shunt was observed.Reportedly, the shunt was unrelated to any mitraclip device.The mitraclips remained fixed, without a device deficiency.The mr remained grade 1+.On (b)(6)2023, a diagnostic right ventricular catheterization was performed with post-capillary mixed pulmonary hypertension diagnosed.Per physician, the events (excluding the shunt) might be related to the mitraclip device due to the increased mitral valve pressure gradient.Mitral valve stenosis is being considered due to the clip device.Medications had been provided as treatment.On (b)(6)2023, the patient was discharged from the hospital with medication.No additional information was provided regarding this issue.
|
|
Manufacturer Narrative
|
The device was not returned for analysis.A review of the lot history record revealed no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Based on available information, the reported mitral stenosis (medical therapy) appears to be due to procedural circumstances (clip implant interacting with patient pathology/ morphology).The cause of the reported angina (treatment with medication(s)) associated with the chest tightness, the reported dyspnea (treatment with medication(s)), the reported heart failure/congestive heart failure (treatment with medication(s)), the reported hypertension (treatment with medication(s)), the reported pleural effusion, the reported pulmonary edema (treatment with medication(s)) associated with the lung exudation, and the reported tricuspid valve insufficiency/ regurgitation associated with the mild tr, could not be determined.The reported patient effects of dyspnea, heart failure, mitral stenosis, hypertension, tricuspid regurgitation, effusion, angina, and pulmonary edema, as listed in the mitraclip system instructions for use, are known possible complications associated with mitraclip procedures.The reported medication required and hospitalization were results of case-specific circumstances.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
|
|
Search Alerts/Recalls
|
|